Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-017730
Filing Date
2016-01-13
Accepted
2016-01-13 17:09:17
Documents
2
Period of Report
2016-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1760
2 EX-24 ex24haviland.txt EX-24 4346
  Complete submission text file 0001179110-16-017730.txt   7470
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
Haviland Kate (Reporting) CIK: 0001663022 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37359 | Film No.: 161341290